# K220353: Disposal Medical Nitrile Examination Gloves-Tested for Use with Chemotherapy Drugs

- Pathway: 510(k) (Traditional)
- Applicant: Niujian Technology Co., Ltd.
- Decided: Mar 31, 2022 after 51 days
- Product code: LZC (Medical Glove, Specialty)
- Device class: 1
- Regulation: 21 CFR 880.6250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Indications for use
This device is intended for medical purpose that is worn on the examiner’s hand to prevent contamination between patient and examiner. In addition, these gloves were tested for use with the following chemotherapy drug concentrations per ASTM D6978-05(2019): The following drugs had NO breakthrough detected up to 240 minutes: Test Chemotherapy Drugs — Minimum Breakthrough Detection Time (Minutes) Cisplatin,1.0 mg/ml (1,000 ppm) — >240 min. Cyclophosphamide (Cytoxan),20.0 mg/ml (20,000 ppm) — >240 min. Dacarbazine,10.0 mg/ml (10,000 ppm) — >240 min. Doxorubicin HCI, 2.0 mg/ml (2,000 ppm) — >240 min. Etoposide, 20.0 mg/ml (20,000 ppm) — >240 min. Fluorouracil,50.0 mg/ml (50,000 ppm) — >240 min. Paclitaxel,6.0 mg/ml (6,000 ppm) — >240 min. Carmustine (BCNU) 3.3 mg/ml (3,300 ppm), — 38.7 min. ThioTepa10.0 mg/ml (10,000 ppm), — 56.9 min Please note that the following drug has low permeation times of less than 60 minutes: Carmustine (BCNU) 3.3 mg/ml (3,300 ppm), 38.7minutes ThioTepa10.0 mg/ml (10,000 ppm),56.9 minutes WARNING: Do not use Carmustine and Thiotepa

Source page: https://510kreport.com/device/K220353
Methodology: https://510kreport.com/methodology